UNSPSC 85816129: Introduction of low-dose interleukin-2 into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E05303

UNSPSC 85816129 Introduction of low-dose interleukin-2 into peripheral artery, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity aligned with its medical procedure scope.

The recent opportunities tagged under this code span virtual urgent care services, occupational health and wellness services, cancer screening, employee wellness platforms, opioid use disorder treatment and recovery programs, behavioral health services, emergency medical services staffing, and inmate healthcare—none of which involve interleukin-2 infusion procedures or interventional vascular services. The mismatch between the code's clinical-procedure specificity and the broad telehealth, occupational medicine, and behavioral health work actually being solicited suggests either a cataloging error or that state and local bodies are using this code to tag activities outside its intended commodity scope. Issuing bodies include state health departments and authorities (Nevada Health Authority, Colorado Department of Human Services, Texas Health and Human Services Commission), counties (DeKalb County Georgia, Ventura County, Sedgwick County Kansas, San Mateo County, Boulder County), cities (Phoenix, Atlanta, Ocala), and specialized districts (Santa Clara Health System, Events DC). Geographic activity spans California, Colorado, Georgia, Kansas, Nevada, Florida, Texas, Illinois, Oregon, Arizona, and the District of Columbia, reflecting nationwide state and local health-system procurement. The most recent opportunities in the block—Nevada Health Authority's PACE program (RFP 41NHA-S4038, proposals due December 10, 2026) and its Rural Value Acceleration Network initiative (RFP 41NHA-S4031, proposals due November 30, 2026)—illustrate the actual scope: integrated care delivery, care coordination, and value-based payment models, not pharmaceutical or procedural interventions. This code generates no actionable business development signal for firms offering interventional cardiology, vascular access, or immunotherapy services to state and local bodies.